John H Fitchen

Title: Innovations of John H. Fitchen

Introduction

John H. Fitchen is a notable inventor based in La Jolla, CA (US). He has made significant contributions to the field of biomedical research, particularly in the development of targeting agents for epithelial tissue. With a total of 8 patents to his name, Fitchen's work has the potential to impact therapeutic delivery systems.

Latest Patents

Fitchen's latest patents include an "Epithelial tissue targeting agent," which discloses targeting molecules designed for delivering biological agents to epithelial tissue. These agents can either remain within an epithelial cell or undergo transepithelial transport via transcytosis. This innovation is particularly useful for the delivery of therapeutic agents. Another significant patent is the "Targeting molecule linked to an imaging agent." This patent describes targeting molecules that facilitate the delivery of imaging agents to epithelial tissue. The targeting molecule consists of a polypeptide that forms a closed covalent loop and contains multiple peptide domains with β-sheet character. This molecule specifically binds to a basolateral factor on the epithelial cell surface, enabling the internalization of a linked imaging agent.

Career Highlights

Throughout his career, John H. Fitchen has worked with prominent organizations such as Epicyte Pharmaceutical, Inc. and The Scripps Research Institute. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Fitchen has collaborated with notable colleagues, including Mich B. Hein and Andrew C. Hiatt. These collaborations have further enriched his research and innovations in the field.

Conclusion

John H. Fitchen's contributions to biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic delivery systems.